Clinical Trial Update: Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose naltrexone against standard antiretroviral therapy in HIV-positive individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Antiretroviral therapy
• Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: The Ojai Foundation | Conditions: HIV Seropositivity | Phase 2 | Status: COMPLETED